{
    "eid": "2-s2.0-85050766406",
    "title": "Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuroscience (all)",
            "@code": "2800",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Toxicology",
            "@code": "3005",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Cytokines",
        "Immune",
        "Inflammation",
        "Interleukin",
        "Neurocognition",
        "Schizophrenia"
    ],
    "authors": [
        "Sunee Sirivichayakul",
        "Buranee Kanchanatawan",
        "Supaksorn Thika",
        "Andr\u00e9 F. Carvalho",
        "Michael Maes"
    ],
    "citedby-count": 42,
    "ref-count": 69,
    "ref-list": [
        "From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation",
        "Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats",
        "The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations",
        "Thought, language, and communication in schizophrenia: diagnosis and prognosis",
        "Negative v positive schizophrenia. Definition and validation",
        "Formal thought disorder in first-episode psychosis",
        "Is working memory still working?",
        "CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging",
        "Controlling the false discovery rate: a practical and powerful approach to multiple testing",
        "Is semantic verbal fluency impairment explained by executive function deficits in schizophrenia?",
        "MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer\u2019s disease dementia phenotypes",
        "Cognitive status is associated with CCL11 in older rural dwellers: findings from the FRAILOMIC study",
        "CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer\u2019s disease",
        "Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions",
        "Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells",
        "Explaining the symptoms of schizophrenia: abnormalities in the awareness of action",
        "Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study",
        "Cognitive functioning in prodromal psychosis: a meta-analysis",
        "Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer\u2019s disease neuroimaging initiative",
        "Gender differences in schizophrenia",
        "The assessment of anxiety states by rating",
        "Negative symptoms and cognitive deficits: what is the nature of their relationship?",
        "The role of sex hormones in the development of Th2 immunity in a gender-biased model of Trichuris muris infection",
        "The \u201caging factor\u201d eotaxin-1 (CCL11) is detectable in transfusion blood products and increases with the donor\u2019s age",
        "Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: results of unsupervised machine learning analysis",
        "Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "The relationship between formal thought disorder and executive functioning component processes",
        "Formal thought disorders: from phenomenology to neurobiology",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer\u2019s disease",
        "Schizophrenic syndromes, cognitive performance and neurological dysfunction",
        "Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine",
        "Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression",
        "The language of schizophrenia: a review and interpretation",
        "Ordering thoughts on thought disorder",
        "Systemic factors mediate reversible age-associated brain dysfunction",
        "IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy",
        "Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis",
        "High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance",
        "Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis",
        "Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic na\u00efve first episode psychosis",
        "Executive functioning in schizophrenia",
        "The brief psychiatric rating scale",
        "Differences in eotaxin serum levels patients with recent onset and in chronic stable schizophrenia: a clue for understanding accelerating aging profile",
        "IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism",
        "Working memory maintenance contributes to long-term memory formation: neural and behavioral evidence",
        "The prognostic value of formal thought disorder following first episode psychosis",
        "Chemokines as modulators of neuroendocrine functions",
        "CCL11 (eotaxin-1) levels predict long-term functional outcomes in patients following ischemic stroke",
        "Measuring thought disorder with clinical rating scales in schizophrenic and nonschizophrenic patients",
        "Gray matter regions statistically mediating the cross-sectional association of eotaxin and set-shifting among older adults with major depressive disorder",
        "Neurocognitive and social cognitive correlates of formal thought disorder in schizophrenia patients",
        "Influence of age and gender on serum eotaxin concentration in healthy and allergic people",
        "Increased serum levels of CCL11/eotaxin in schizophrenia",
        "The ageing systemic milieu negatively regulates neurogenesis and cognitive function",
        "Effects of facial nerve axotomy on Th2- and Th1-associated chemokine expression in the facial motor nucleus of wild-type and presymptomatic mSOD1 mice",
        "Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells",
        "Mediation of episodic memory performance by the executive function network in patients with amnestic mild cognitive impairment: a resting-state functional MRI study",
        "A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)",
        "Targeting CCR3 to reduce amyloid-\u03b2 production, tau hyperphosphorylation, and synaptic loss in a mouse model of Alzheimer\u2019s disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Ratchadapiseksompotch Fund",
        "Asahi Glass Foundation",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}